BBLG earnings date and last-quarter result: next report 2026-08-13, last quarter in line, P/E -0.40. Updated 2026-07-23.
Bone Biologics (BBLG) Research Hub
Bone Biologics (BBLG) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.377 USD (-4.51%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.40, market cap 0.00B. This hub links to the full technical, earnings and options research available for BBLG.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.377 USD (-4.51%) |
| 52-week range | 0.37 USD – 1.54 USD |
| Trend regime | Range |
| 14-day RSI | 24.8 (Oversold) |
| Trailing P/E | -0.40 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for BBLG
Covered Call on BBLG: how it works, illustrative setup around the real 0.377 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BBLG: how it works, illustrative setup around the real 0.377 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BBLG: how it works, illustrative setup around the real 0.377 USD price, max profit/loss, breakeven and when to use it. Educational.
BBLG technical analysis: range, last 0.377 USD, RSI 24.8, 52w range 0.37 USD–1.54 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BBLG in?
Bone Biologics (BBLG) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BBLG in an uptrend or downtrend?
As of 2026-10-26, BBLG is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BBLG's trailing P/E ratio?
BBLG's trailing P/E is -0.40, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does BBLG next report earnings?
BBLG is next scheduled to report earnings on 2026-08-13.